BioSpace News Archive

Aviragen Adjourns Special Meeting of Stockholders Until February 9, 2018

Aviragen intends to reconvene the Special Meeting on February 9, 2018 at 12:00 pm EST.

February 7, 2018

·

7 min read

Bavarian Nordic Announces Positive Results of Pivotal Phase III Study of IMVAMUNE Smallpox Vaccine

In this randomized, open-label study of 440 volunteers, the peak neutralizing antibodies induced by IMVAMUNE were shown to be 2-fold higher than those stimulated by ACAM2000.

February 7, 2018

·

6 min read

Policy

GamaMabs Pharma Receives Orphan Drug Designation From US FDA for Lead Compound GM102

GM102 is a first-in-class monoclonal antibody targeting AMHR2-expressing tumors.

February 7, 2018

·

2 min read

Business

Palatin Technologies to Report Second Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on February 12, 2018

Palatin Technologies will announce its second quarter, fiscal year 2018 operating results on Monday, February 12, 2018 before the open of the U.S. financial markets.

February 7, 2018

·

1 min read

Business

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2017

Enanta’s cash, cash equivalents and short-term and long-term marketable securities totaled $297.5 million at December 31, 2017.

February 7, 2018

·

11 min read

Genetown

Sage Therapeutics Announces Proposed Public Offering of $575 Million of its Common Stock

Sage Therapeutics today announced that it has commenced an underwritten public offering of $575.0 million of its common stock.

February 7, 2018

·

4 min read

Business

Taro Provides Results for December 31, 2017

Cash flow provided by operations for the nine months ended December 31, 2017, was $225.8 million compared to $320.5 million for the nine months ended December 31, 2016.

February 7, 2018

·

12 min read

Business

Quidel to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on February 21, 2018

Following the release of results, Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will host an investment community conference call beginning at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the results and answer questions.

February 7, 2018

·

2 min read

Biotech Beach

Evolus Announces Pricing of Initial Public Offering of Common Stock

Evolus has also granted the underwriters a 30-day option to purchase an additional 750,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.

February 7, 2018

·

3 min read

Business

ProBioGen and TEVA Sign License Agreement on Human Artificial Lymph Node Technology

The unique human Artificial Lymph Node model was developed by ProBioGen as superior 3D-micro-organoid model for analyzing substance effects on the human immune system in vitro.

February 7, 2018

·

3 min read